{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T09:04:20Z","timestamp":1772701460966,"version":"3.50.1"},"reference-count":223,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Dopamine is a catecholamine that acts as a modulatory neurotransmitter in the central nervous system. Although dopamine levels are kept within appropriate ranges through various mechanisms, they can be disrupted by multiple factors, including external psychostimulants such as cocaine and methamphetamine. Disruption contributes to cognitive deficits and emotional dysregulation that is associated with psychostimulant-use disorders (PSUD). These stimulants interfere with the dopamine system through various mechanisms that affect its synthesis, storage, release, reuptake, and degradation. Such changes have neurobiological effects, including receptor desensitization, oxidative stress, and neuronal damage, highlighting the importance of maintaining a balanced dopamine system. This review offers a comprehensive overview of how psychostimulants like cocaine and methamphetamine disrupt dopamine synthesis, storage, release, and reuptake, examines the neurobiological consequences of these disruptions, and proposes directions for future research on mechanisms and the development of novel neuroprotective therapies.<\/jats:p>","DOI":"10.1007\/s12035-026-05769-0","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T08:26:54Z","timestamp":1772699214000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disruption of Dopamine Homeostasis by Psychostimulants"],"prefix":"10.1007","volume":"63","author":[{"given":"Juan","family":"Torres","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colton","family":"Bredenkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atzin","family":"Vazquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernest T.","family":"Chivero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"5769_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.neulet.2008.04.034","volume":"438","author":"M Ito","year":"2008","unstructured":"Ito M, Numachi Y, Ohara A, Sora I (2008) Hyperthermic and lethal effects of methamphetamine: roles of dopamine D1 and D2 receptors. Neurosci Lett 438:327\u2013329. https:\/\/doi.org\/10.1016\/j.neulet.2008.04.034","journal-title":"Neurosci Lett"},{"key":"5769_CR2","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1046\/j.1460-9568.1999.00764.x","volume":"11","author":"M Jaber","year":"1999","unstructured":"Jaber M, Dumartin B, Sagn\u00e9 C et al (1999) Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter. Eur J Neurosci 11:3499\u20133511. https:\/\/doi.org\/10.1046\/j.1460-9568.1999.00764.x","journal-title":"Eur J Neurosci"},{"key":"5769_CR3","doi-asserted-by":"publisher","first-page":"4029","DOI":"10.1073\/pnas.95.7.4029","volume":"95","author":"SR Jones","year":"1998","unstructured":"Jones SR, Gainetdinov RR, Jaber M et al (1998) Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci U S A 95:4029\u20134034","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5769_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/9730467","volume":"2016","author":"H Ju\u00e1rez Olgu\u00edn","year":"2016","unstructured":"Ju\u00e1rez Olgu\u00edn H, Calder\u00f3n Guzm\u00e1n D, Hern\u00e1ndez Garc\u00eda E, Barrag\u00e1n Mej\u00eda G (2016) The role of dopamine and its dysfunction as a consequence of oxidative stress. Oxid Med Cell Longev 2016:9730467. https:\/\/doi.org\/10.1155\/2016\/9730467","journal-title":"Oxid Med Cell Longev"},{"key":"5769_CR5","doi-asserted-by":"publisher","unstructured":"Vecchio LM, Sullivan P, Dunn AR, et al (2021) Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo - Vecchio - 2021 - Journal of Neurochemistry - Wiley Online Library. https:\/\/onlinelibrary-wiley-com.leo.lib.unomaha.edu\/doi\/full\/,\u00a0https:\/\/doi.org\/10.1111\/jnc.15432. Accessed 10 Jan 2025","DOI":"10.1111\/jnc.15432"},{"key":"5769_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00186","author":"X Yang","year":"2018","unstructured":"Yang X, Wang Y, Li Q et al (2018) The main molecular mechanisms underlying methamphetamine- induced neurotoxicity and implications for pharmacological treatment. Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2018.00186","journal-title":"Front Mol Neurosci"},{"key":"5769_CR7","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1523\/JNEUROSCI.3422-13.2015","volume":"35","author":"CA Mejias-Aponte","year":"2015","unstructured":"Mejias-Aponte CA, Ye C, Bonci A et al (2015) A subpopulation of neurochemically-identified ventral tegmental area dopamine neurons is excited by intravenous cocaine. J Neurosci 35:1965\u20131978. https:\/\/doi.org\/10.1523\/JNEUROSCI.3422-13.2015","journal-title":"J Neurosci"},{"key":"5769_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neuroscience.2011.08.023","volume":"198","author":"H Morikawa","year":"2011","unstructured":"Morikawa H, Paladini CA (2011) Dynamic regulation of midbrain dopamine neuron activity: intrinsic, synaptic, and plasticity mechanisms. Neuroscience 198:95\u2013111. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.08.023","journal-title":"Neuroscience"},{"key":"5769_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2019.00334","author":"Y Ranjbar-Slamloo","year":"2020","unstructured":"Ranjbar-Slamloo Y, Fazlali Z (2020) Dopamine and noradrenaline in the brain; overlapping or dissociate functions? Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2019.00334","journal-title":"Front Mol Neurosci"},{"key":"5769_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00213-014-3632-0","volume":"232","author":"N Rodriguez-Espinosa","year":"2015","unstructured":"Rodriguez-Espinosa N, Fernandez-Espejo E (2015) Effects of acute and repeated cocaine on markers for neural plasticity within the mesolimbic system in rats. Psychopharmacology 232:57\u201362. https:\/\/doi.org\/10.1007\/s00213-014-3632-0","journal-title":"Psychopharmacology"},{"key":"5769_CR11","doi-asserted-by":"crossref","unstructured":"Schmidt HD, Pierce RC (2013) Chapter 25 - The role of glutamate receptors in addiction. In: Miller PM (ed) Biological Research on Addiction. Academic Press, San Diego, pp 241\u2013250","DOI":"10.1016\/B978-0-12-398335-0.00025-X"},{"key":"5769_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/09595230801923702","volume":"27","author":"S Darke","year":"2008","unstructured":"Darke S, Kaye S, McKetin R, Duflou J (2008) Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev 27:253\u2013262. https:\/\/doi.org\/10.1080\/09595230801923702","journal-title":"Drug Alcohol Rev"},{"key":"5769_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.disamonth.2008.10.002","volume":"55","author":"RA Goldstein","year":"2009","unstructured":"Goldstein RA, DesLauriers C, Burda AM (2009) Cocaine: history, social implications, and toxicity\u2014a review. Dis Mon 55:6\u201338. https:\/\/doi.org\/10.1016\/j.disamonth.2008.10.002","journal-title":"Dis Mon"},{"key":"5769_CR14","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/09595230801919460","volume":"27","author":"JC Maxwell","year":"2008","unstructured":"Maxwell JC, Rutkowski BA (2008) The prevalence of methamphetamine and amphetamine abuse in North America: a review of the indicators, 1992\u20132007. Drug Alcohol Rev 27:229\u2013235. https:\/\/doi.org\/10.1080\/09595230801919460","journal-title":"Drug Alcohol Rev"},{"key":"5769_CR15","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1017\/S0022215100088289","volume":"93","author":"K Pearman","year":"1979","unstructured":"Pearman K (1979) Cocaine: a review. J Laryngol Otol 93:1191\u20131199. https:\/\/doi.org\/10.1017\/S0022215100088289","journal-title":"J Laryngol Otol"},{"key":"5769_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.18514","volume":"3","author":"RK Twillman","year":"2020","unstructured":"Twillman RK, Dawson E, LaRue L et al (2020) Evaluation of trends of near-real-time urine drug test results for methamphetamine, cocaine, heroin, and fentanyl. JAMA Netw Open 3:e1918514. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.18514","journal-title":"JAMA Netw Open"},{"key":"5769_CR17","unstructured":"2021 NSDUH Detailed Tables | CBHSQ Data. https:\/\/www.samhsa.gov\/data\/report\/2021-nsduh-detailed-tables. Accessed 14 Jan 2025"},{"key":"5769_CR18","unstructured":"Abuse NI on D (2024) Drug overdose deaths: facts and figures | National Institute on Drug Abuse (NIDA). https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates. Accessed 14 Jan 2025"},{"key":"5769_CR19","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.nbd.2011.11.005","volume":"45","author":"S Ares-Santos","year":"2012","unstructured":"Ares-Santos S, Granado N, Oliva I et al (2012) Dopamine D1 receptor deletion strongly reduces neurotoxic effects of methamphetamine. Neurobiol Dis 45:810\u2013820. https:\/\/doi.org\/10.1016\/j.nbd.2011.11.005","journal-title":"Neurobiol Dis"},{"key":"5769_CR20","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1111\/joim.12049","volume":"273","author":"S Ares-Santos","year":"2013","unstructured":"Ares-Santos S, Granado N, Moratalla R (2013) The role of dopamine receptors in the neurotoxicity of methamphetamine. J Intern Med 273:437\u2013453. https:\/\/doi.org\/10.1111\/joim.12049","journal-title":"J Intern Med"},{"key":"5769_CR21","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.nbd.2011.01.033","volume":"42","author":"N Granado","year":"2011","unstructured":"Granado N, Ares-Santos S, Oliva I et al (2011) Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA. Neurobiol Dis 42:391\u2013403. https:\/\/doi.org\/10.1016\/j.nbd.2011.01.033","journal-title":"Neurobiol Dis"},{"key":"5769_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0304-3940(96)13047-0","volume":"217","author":"JM Masserano","year":"1996","unstructured":"Masserano JM, Baker I, Natsukari N, Wyatt RJ (1996) Chronic cocaine administration increases tyrosine hydroxylase activity in the ventral tegmental area through glutaminergic- and dopaminergic D2-receptor mechanisms. Neurosci Lett 217:73\u201376. https:\/\/doi.org\/10.1016\/0304-3940(96)13047-0","journal-title":"Neurosci Lett"},{"key":"5769_CR23","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1111\/j.1471-4159.1993.tb13405.x","volume":"60","author":"SJ O\u2019Dell","year":"1993","unstructured":"O\u2019Dell SJ, Weihmuller FB, Marshall JF (1993) Methamphetamine-induced dopamine overflow and injury to striatal dopamine terminals: attenuation by dopamine D1 or D2 antagonists. J Neurochem 60:1792\u20131799. https:\/\/doi.org\/10.1111\/j.1471-4159.1993.tb13405.x","journal-title":"J Neurochem"},{"key":"5769_CR24","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/syn.20185","volume":"58","author":"W Xu","year":"2005","unstructured":"Xu W, Zhu JPQ, Angulo JA (2005) Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors. Synapse 58:110\u2013121. https:\/\/doi.org\/10.1002\/syn.20185","journal-title":"Synapse"},{"key":"5769_CR25","doi-asserted-by":"publisher","first-page":"802","DOI":"10.2174\/1570159X13666150612225836","volume":"13","author":"A Qayyum","year":"2015","unstructured":"Qayyum A, Zai CC, Hirata Y et al (2015) The role of the catechol-o-methyltransferase (COMT) gene Val158Met in aggressive behavior, a review of genetic studies. Curr Neuropharmacol 13:802\u2013814. https:\/\/doi.org\/10.2174\/1570159X13666150612225836","journal-title":"Curr Neuropharmacol"},{"key":"5769_CR26","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1038\/s12276-021-00646-3","volume":"53","author":"H-U Cho","year":"2021","unstructured":"Cho H-U, Kim S, Sim J et al (2021) Redefining differential roles of MAO-A in dopamine degradation and MAO-B in tonic GABA synthesis. Exp Mol Med 53:1148\u20131158. https:\/\/doi.org\/10.1038\/s12276-021-00646-3","journal-title":"Exp Mol Med"},{"key":"5769_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11064-017-2318-5","volume":"43","author":"S Eun-Joo","year":"2018","unstructured":"Eun-Joo S, Tran H-Q, Nguyen P-T et al (2018) Role of mitochondria in methamphetamine-induced dopaminergic neurotoxicity: involvement in oxidative stress, neuroinflammation, and pro-apoptosis\u2014a review. Neurochem Res 43:57\u201369. https:\/\/doi.org\/10.1007\/s11064-017-2318-5","journal-title":"Neurochem Res"},{"key":"5769_CR28","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/S0896-6273(00)80418-3","volume":"19","author":"EA Fon","year":"1997","unstructured":"Fon EA, Pothos EN, Sun B-C et al (1997) Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action. Neuron 19:1271\u20131283. https:\/\/doi.org\/10.1016\/S0896-6273(00)80418-3","journal-title":"Neuron"},{"key":"5769_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1478-811X-11-34","volume":"11","author":"J Meiser","year":"2013","unstructured":"Meiser J, Weindl D, Hiller K (2013) Complexity of dopamine metabolism. Cell Commun Signal 11:34. https:\/\/doi.org\/10.1186\/1478-811X-11-34","journal-title":"Cell Commun Signal"},{"key":"5769_CR30","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1111\/j.1471-4159.2010.06723.x","volume":"113","author":"TT My\u00f6h\u00e4nen","year":"2010","unstructured":"My\u00f6h\u00e4nen TT, Schendzielorz N, M\u00e4nnist\u00f6 PT (2010) Distribution of catechol-O-methyltransferase (COMT) proteins and enzymatic activities in wild-type and soluble COMT deficient mice. J Neurochem 113:1632\u20131643. https:\/\/doi.org\/10.1111\/j.1471-4159.2010.06723.x","journal-title":"J Neurochem"},{"key":"5769_CR31","first-page":"35","volume":"45","author":"A Napolitano","year":"1995","unstructured":"Napolitano A, Cesura AM, Da Prada M (1995) The role of monoamine oxidase and catechol O-methyltransferase in dopaminergic neurotransmission. J Neural Transm Suppl 45:35\u201345","journal-title":"J Neural Transm Suppl"},{"key":"5769_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2010.12.017","volume":"508","author":"SC Daubner","year":"2011","unstructured":"Daubner SC, Le T, Wang S (2011) Tyrosine hydroxylase and regulation of dopamine synthesis. Arch Biochem Biophys 508:1\u201312. https:\/\/doi.org\/10.1016\/j.abb.2010.12.017","journal-title":"Arch Biochem Biophys"},{"key":"5769_CR33","doi-asserted-by":"publisher","first-page":"1539S","DOI":"10.1093\/jn\/137.6.1539S","volume":"137","author":"JD Fernstrom","year":"2007","unstructured":"Fernstrom JD, Fernstrom MH (2007) Tyrosine, phenylalanine, and catecholamine synthesis and function in the brain123. J Nutr 137:1539S-1547S. https:\/\/doi.org\/10.1093\/jn\/137.6.1539S","journal-title":"J Nutr"},{"key":"5769_CR34","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1046\/j.1471-4159.2002.00982.x","volume":"82","author":"JP Jedynak","year":"2002","unstructured":"Jedynak JP, Ali SF, Haycock JW, Hope BT (2002) Acute administration of cocaine regulates the phosphorylation of serine-19, -31 and -40 in tyrosine hydroxylase. J Neurochem 82:382\u2013388. https:\/\/doi.org\/10.1046\/j.1471-4159.2002.00982.x","journal-title":"J Neurochem"},{"key":"5769_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.brainres.2004.03.043","volume":"1012","author":"SC Licata","year":"2004","unstructured":"Licata SC, Pierce RC (2004) Repeated cocaine injections have no influence on tyrosine hydroxylase activity in the rat nucleus accumbens core or shell. Brain Res 1012:119\u2013126. https:\/\/doi.org\/10.1016\/j.brainres.2004.03.043","journal-title":"Brain Res"},{"key":"5769_CR36","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S0361-9230(00)00277-X","volume":"52","author":"MS Todtenkopf","year":"2000","unstructured":"Todtenkopf MS, De Leon KR, Stellar JR (2000) Repeated cocaine treatment alters tyrosine hydroxylase in the rat nucleus accumbens. Brain Res Bull 52:407\u2013411. https:\/\/doi.org\/10.1016\/S0361-9230(00)00277-X","journal-title":"Brain Res Bull"},{"key":"5769_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105409","volume":"156","author":"SM Graves","year":"2021","unstructured":"Graves SM, Schwarzschild SE, Tai RA et al (2021) Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons. Neurobiol Dis 156:105409. https:\/\/doi.org\/10.1016\/j.nbd.2021.105409","journal-title":"Neurobiol Dis"},{"key":"5769_CR38","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4982453","volume":"2018","author":"F Limanaqi","year":"2018","unstructured":"Limanaqi F, Gambardella S, Biagioni F et al (2018) Epigenetic effects induced by methamphetamine and methamphetamine-dependent oxidative stress. Oxid Med Cell Longev 2018:4982453. https:\/\/doi.org\/10.1155\/2018\/4982453","journal-title":"Oxid Med Cell Longev"},{"key":"5769_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.baga.2011.11.004","volume":"2","author":"H Zhang","year":"2012","unstructured":"Zhang H, Sulzer D (2012) Regulation of striatal dopamine release by presynaptic auto- and heteroreceptors. Basal Ganglia 2:5\u201313. https:\/\/doi.org\/10.1016\/j.baga.2011.11.004","journal-title":"Basal Ganglia"},{"key":"5769_CR40","first-page":"273","volume":"42","author":"AA Boulton","year":"1998","unstructured":"Boulton AA, Eisenhofer G (1998) Catecholamine metabolism. From molecular understanding to clinical diagnosis and treatment. Overview. Adv Pharmacol San Diego Calif 42:273\u2013292","journal-title":"Adv Pharmacol San Diego Calif"},{"key":"5769_CR41","doi-asserted-by":"publisher","first-page":"4707","DOI":"10.1523\/JNEUROSCI.16-15-04707.1996","volume":"16","author":"MT Berhow","year":"1996","unstructured":"Berhow MT, Hiroi N, Nestler EJ (1996) Regulation of ERK ( extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J Neurosci 16:4707\u20134715. https:\/\/doi.org\/10.1523\/JNEUROSCI.16-15-04707.1996","journal-title":"J Neurosci"},{"key":"5769_CR42","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1111\/jnc.13209","volume":"134","author":"AP Escobar","year":"2015","unstructured":"Escobar AP, Cornejo FA, Olivares-Costa M et al (2015) Reduced dopamine and glutamate neurotransmission in the nucleus accumbens of quinpirole-sensitized rats hints at inhibitory D2 autoreceptor function. J Neurochem 134:1081\u20131090. https:\/\/doi.org\/10.1111\/jnc.13209","journal-title":"J Neurochem"},{"key":"5769_CR43","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1046\/j.1471-4159.2002.00811.x","volume":"81","author":"BT Chen","year":"2002","unstructured":"Chen BT, Rice ME (2002) Synaptic regulation of somatodendritic dopamine release by glutamate and GABA differs between substantia nigra and ventral tegmental area. J Neurochem 81:158\u2013169. https:\/\/doi.org\/10.1046\/j.1471-4159.2002.00811.x","journal-title":"J Neurochem"},{"key":"5769_CR44","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/ejn.16123","volume":"59","author":"H Sotoyama","year":"2024","unstructured":"Sotoyama H (2024) Putative neural mechanisms underlying release-mode-specific abnormalities in dopamine neural activity in a schizophrenia-like model: the distinct roles of glutamate and serotonin in the impaired regulation of dopamine neurons. Eur J Neurosci 59:1194\u20131212. https:\/\/doi.org\/10.1111\/ejn.16123","journal-title":"Eur J Neurosci"},{"key":"5769_CR45","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1046\/j.1471-4159.1997.69010137.x","volume":"69","author":"S Ikemoto","year":"1997","unstructured":"Ikemoto S, Kohl RR, McBride WJ (1997) GABAA receptor blockade in the anterior ventral tegmental area increases extracellular levels of dopamine in the nucleus accumbens of rats. J Neurochem 69:137\u2013143. https:\/\/doi.org\/10.1046\/j.1471-4159.1997.69010137.x","journal-title":"J Neurochem"},{"key":"5769_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18247-5","volume":"11","author":"BM Roberts","year":"2020","unstructured":"Roberts BM, Doig NM, Brimblecombe KR et al (2020) GABA uptake transporters support dopamine release in dorsal striatum with maladaptive downregulation in a parkinsonism model. Nat Commun 11:4958. https:\/\/doi.org\/10.1038\/s41467-020-18247-5","journal-title":"Nat Commun"},{"key":"5769_CR47","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.brainres.2007.02.081","volume":"1150","author":"M Doherty","year":"2007","unstructured":"Doherty M, Gratton A (2007) Differential involvement of ventral tegmental GABAA and GABAB receptors in the regulation of the nucleus accumbens dopamine response to stress. Brain Res 1150:62\u201368. https:\/\/doi.org\/10.1016\/j.brainres.2007.02.081","journal-title":"Brain Res"},{"key":"5769_CR48","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/npp.2014.30","volume":"39","author":"ES Calipari","year":"2014","unstructured":"Calipari ES, Sun H, Eldeeb K et al (2014) Amphetamine self-administration attenuates dopamine D2 autoreceptor function. Neuropsychopharmacology 39:1833\u20131842. https:\/\/doi.org\/10.1038\/npp.2014.30","journal-title":"Neuropsychopharmacology"},{"key":"5769_CR49","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202412229","author":"X Sun","year":"2025","unstructured":"Sun X, Yin L, Qiao Z et al (2025) Action potential firing patterns regulate dopamine release via voltage\u2010sensitive dopamine D2 autoreceptors in mouse striatum in vivo. Adv Sci. https:\/\/doi.org\/10.1002\/advs.202412229","journal-title":"Adv Sci"},{"key":"5769_CR50","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1111\/jnc.12229","volume":"125","author":"R Chen","year":"2013","unstructured":"Chen R, Daining CP, Sun H et al (2013) Protein kinase C\u03b2 is a modulator of the dopamine D2 autoreceptor-activated trafficking of the dopamine transporter. J Neurochem 125:663\u2013672. https:\/\/doi.org\/10.1111\/jnc.12229","journal-title":"J Neurochem"},{"key":"5769_CR51","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.12004","volume":"2","author":"S Koyama","year":"2014","unstructured":"Koyama S, Mori M, Kanamaru S et al (2014) Obesity attenuates D2 autoreceptor-mediated inhibition of putative ventral tegmental area dopaminergic neurons. Physiol Rep 2:e12004. https:\/\/doi.org\/10.14814\/phy2.12004","journal-title":"Physiol Rep"},{"key":"5769_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04728-z","volume":"7","author":"BG Robinson","year":"2017","unstructured":"Robinson BG, Bunzow JR, Grimm JB et al (2017) Desensitized D2 autoreceptors are resistant to trafficking. Sci Rep 7:4379. https:\/\/doi.org\/10.1038\/s41598-017-04728-z","journal-title":"Sci Rep"},{"key":"5769_CR53","unstructured":"Miller PM (2013) Principles of addiction: comprehensive addictive behaviors and disorders, Edition 1, Volume 1. Elsevier Science & Technology, Chantilly, UNITED STATES"},{"key":"5769_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/toxins14040278","volume":"14","author":"R Roque Bravo","year":"2022","unstructured":"Roque Bravo R, Faria AC, Brito-da-Costa AM et al (2022) Cocaine: an updated overview on chemistry, detection, biokinetics, and pharmacotoxicological aspects including abuse pattern. Toxins 14:278. https:\/\/doi.org\/10.3390\/toxins14040278","journal-title":"Toxins"},{"key":"5769_CR55","doi-asserted-by":"publisher","first-page":"e781","DOI":"10.4088\/JCP.14f09362","volume":"75","author":"C Andrade","year":"2014","unstructured":"Andrade C (2014) Cause versus association in observational studies in psychopharmacology. J Clin Psychiatry 75:e781-784. https:\/\/doi.org\/10.4088\/JCP.14f09362","journal-title":"J Clin Psychiatry"},{"key":"5769_CR56","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.neulet.2006.01.001","volume":"398","author":"C Courtin","year":"2006","unstructured":"Courtin C, Crete D, Canestrelli C et al (2006) Regulation of genes involved in dopamine transporter modulation by acute cocaine in rat striatum. Neurosci Lett 398:235\u2013240. https:\/\/doi.org\/10.1016\/j.neulet.2006.01.001","journal-title":"Neurosci Lett"},{"key":"5769_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41398-023-02493-4","volume":"13","author":"JD Keighron","year":"2023","unstructured":"Keighron JD, Bonaventura J, Li Y et al (2023) Interactions of calmodulin kinase II with the dopamine transporter facilitate cocaine-induced enhancement of evoked dopamine release. Transl Psychiatry 13:1\u201310. https:\/\/doi.org\/10.1038\/s41398-023-02493-4","journal-title":"Transl Psychiatry"},{"key":"5769_CR58","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1126\/science.2903550","volume":"242","author":"GF Koob","year":"1988","unstructured":"Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715\u2013723. https:\/\/doi.org\/10.1126\/science.2903550","journal-title":"Science"},{"key":"5769_CR59","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1151\/spp05314","volume":"3","author":"EJ Nestler","year":"2005","unstructured":"Nestler EJ (2005) The neurobiology of cocaine addiction. Sci Pract Perspect 3:4\u201310. https:\/\/doi.org\/10.1151\/spp05314","journal-title":"Sci Pract Perspect"},{"key":"5769_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232315414","volume":"23","author":"M Pardo","year":"2022","unstructured":"Pardo M, Martin M, Gainetdinov RR et al (2022) Heterozygote dopamine transporter knockout rats display enhanced cocaine locomotion in adolescent females. Int J Mol Sci 23:15414. https:\/\/doi.org\/10.3390\/ijms232315414","journal-title":"Int J Mol Sci"},{"key":"5769_CR61","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0006-8993(00)02057-6","volume":"860","author":"H Tsukada","year":"2000","unstructured":"Tsukada H, Harada N, Nishiyama S et al (2000) Dose\u2013response and duration effects of acute administrations of cocaine and GBR12909 on dopamine synthesis and transporter in the conscious monkey brain: PET studies combined with microdialysis. Brain Res 860:141\u2013148. https:\/\/doi.org\/10.1016\/S0006-8993(00)02057-6","journal-title":"Brain Res"},{"key":"5769_CR62","doi-asserted-by":"publisher","DOI":"10.1111\/adb.13236","volume":"27","author":"J Deng","year":"2022","unstructured":"Deng J, Zheng X, Shang L et al (2022) Gender differences in cocaine-induced hyperactivity and dopamine transporter trafficking to the plasma membrane. Addict Biol 27:e13236. https:\/\/doi.org\/10.1111\/adb.13236","journal-title":"Addict Biol"},{"key":"5769_CR63","doi-asserted-by":"publisher","first-page":"15057","DOI":"10.1021\/jp900963n","volume":"113","author":"X Huang","year":"2009","unstructured":"Huang X, Gu HH, Zhan C-G (2009) Mechanism for cocaine blocking the transport of dopamine: insights from molecular modeling and dynamics simulations. J Phys Chem B 113:15057\u201315066. https:\/\/doi.org\/10.1021\/jp900963n","journal-title":"J Phys Chem B"},{"key":"5769_CR64","doi-asserted-by":"publisher","unstructured":"Saenz J, Yao O, Khezerlou E, et al (2023) Cocaine-regulated trafficking of dopamine transporters in cultured neurons revealed by a pH sensitive reporter. iScience 26:21. https:\/\/doi.org\/10.1016\/j.isci.2022.105782","DOI":"10.1016\/j.isci.2022.105782"},{"key":"5769_CR65","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1111\/j.1471-4159.2008.05323.x","volume":"105","author":"MMM Verheij","year":"2008","unstructured":"Verheij MMM, de Mulder ELW, De Leonibus E et al (2008) Rats that differentially respond to cocaine differ in their dopaminergic storage capacity of the nucleus accumbens. J Neurochem 105:2122\u20132133. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05323.x","journal-title":"J Neurochem"},{"key":"5769_CR66","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a013680","volume":"4","author":"AA Alabi","year":"2012","unstructured":"Alabi AA, Tsien RW (2012) Synaptic vesicle pools and dynamics. Cold Spring Harb Perspect Biol 4:a013680. https:\/\/doi.org\/10.1101\/cshperspect.a013680","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"5769_CR67","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/nature01389","volume":"422","author":"RR Duncan","year":"2003","unstructured":"Duncan RR, Greaves J, Wiegand UK et al (2003) Functional and spatial segregation of secretory vesicle pools according to vesicle age. Nature 422:176\u2013180. https:\/\/doi.org\/10.1038\/nature01389","journal-title":"Nature"},{"key":"5769_CR68","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/S0896-6273(00)80473-0","volume":"20","author":"H Kuromi","year":"1998","unstructured":"Kuromi H, Kidokoro Y (1998) Two distinct pools of synaptic vesicles in single presynaptic boutons in a temperature-sensitive drosophila mutant, shibire. Neuron 20:917\u2013925. https:\/\/doi.org\/10.1016\/S0896-6273(00)80473-0","journal-title":"Neuron"},{"key":"5769_CR69","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/375493a0","volume":"375","author":"VA Pieribone","year":"1995","unstructured":"Pieribone VA, Shupliakov O, Brodin L et al (1995) Distinct pools of synaptic vesicles in neurotransmitter release. Nature 375:493\u2013497. https:\/\/doi.org\/10.1038\/375493a0","journal-title":"Nature"},{"key":"5769_CR70","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/S0896-6273(00)80146-4","volume":"16","author":"C Rosenmund","year":"1996","unstructured":"Rosenmund C, Stevens CF (1996) Definition of the readily releasable pool of vesicles at hippocampal synapses. Neuron 16:1197\u20131207. https:\/\/doi.org\/10.1016\/S0896-6273(00)80146-4","journal-title":"Neuron"},{"key":"5769_CR71","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.pnpbp.2018.10.003","volume":"89","author":"A da Moreira Silva Santos","year":"2019","unstructured":"da Moreira Silva Santos A, Kelly JP, Dockery P, Doyle KM (2019) Effect of a binge-like dosing regimen of methamphetamine on dopamine levels and tyrosine hydroxylase expressing neurons in the rat brain. Prog Neuropsychopharmacol Biol Psychiatry 89:303\u2013309. https:\/\/doi.org\/10.1016\/j.pnpbp.2018.10.003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"5769_CR72","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.pharmthera.2004.12.004","volume":"106","author":"SM Anderson","year":"2005","unstructured":"Anderson SM, Pierce RC (2005) Cocaine-induced alterations in dopamine receptor signaling: implications for reinforcement and reinstatement. Pharmacol Ther 106:389\u2013403. https:\/\/doi.org\/10.1016\/j.pharmthera.2004.12.004","journal-title":"Pharmacol Ther"},{"key":"5769_CR73","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s00429-017-1532-x","volume":"223","author":"MD Santos","year":"2018","unstructured":"Santos MD, Cahill EN, Bo GD et al (2018) Cocaine increases dopaminergic connectivity in the nucleus accumbens. Brain Struct Funct 223:913\u2013923. https:\/\/doi.org\/10.1007\/s00429-017-1532-x","journal-title":"Brain Struct Funct"},{"key":"5769_CR74","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.eurpsy.2019.03.003","volume":"59","author":"L Proebstl","year":"2019","unstructured":"Proebstl L, Kamp F, Manz K et al (2019) Effects of stimulant drug use on the dopaminergic system: a systematic review and meta-analysis of in vivo neuroimaging studies. Eur Psychiatry 59:15\u201324. https:\/\/doi.org\/10.1016\/j.eurpsy.2019.03.003","journal-title":"Eur Psychiatry"},{"key":"5769_CR75","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/syn.890140210","volume":"14","author":"ND Volkow","year":"1993","unstructured":"Volkow ND, Fowler JS, Wang GJ et al (1993) Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 14:169\u2013177. https:\/\/doi.org\/10.1002\/syn.890140210","journal-title":"Synapse"},{"key":"5769_CR76","doi-asserted-by":"publisher","first-page":"3421","DOI":"10.1016\/j.neuron.2021.08.012","volume":"109","author":"S Gong","year":"2021","unstructured":"Gong S, Fayette N, Heinsbroek JA, Ford CP (2021) Cocaine shifts dopamine D2 receptor sensitivity to gate conditioned behaviors. Neuron 109:3421-3435.e5. https:\/\/doi.org\/10.1016\/j.neuron.2021.08.012","journal-title":"Neuron"},{"key":"5769_CR77","doi-asserted-by":"publisher","first-page":"15827","DOI":"10.1523\/JNEUROSCI.1935-13.2013","volume":"33","author":"K Park","year":"2013","unstructured":"Park K, Volkow ND, Pan Y, Du C (2013) Chronic cocaine dampens dopamine signaling during cocaine intoxication and unbalances D1 over D2 receptor signaling. J Neurosci 33:15827\u201315836. https:\/\/doi.org\/10.1523\/JNEUROSCI.1935-13.2013","journal-title":"J Neurosci"},{"key":"5769_CR78","doi-asserted-by":"publisher","DOI":"10.1111\/adb.13053","volume":"26","author":"Y Duan","year":"2021","unstructured":"Duan Y, Meng Y, Du W et al (2021) Increased cocaine motivation in tree shrews is modulated by striatal dopamine D1 receptor-mediated upregulation of Cav1.2. Addict Biol 26:e13053. https:\/\/doi.org\/10.1111\/adb.13053","journal-title":"Addict Biol"},{"key":"5769_CR79","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41386-022-01495-y","volume":"48","author":"SE Swinford-Jackson","year":"2023","unstructured":"Swinford-Jackson SE, Huffman PJ, Knouse MC et al (2023) High frequency DBS-like optogenetic stimulation of nucleus accumbens dopamine D2 receptor-containing neurons attenuates cocaine reinstatement in male rats. Neuropsychopharmacology 48:459\u2013467. https:\/\/doi.org\/10.1038\/s41386-022-01495-y","journal-title":"Neuropsychopharmacology"},{"key":"5769_CR80","doi-asserted-by":"publisher","unstructured":"Yuen J, Goyal A, Rusheen AE, et al (2023) Frontiers | high frequency deep brain stimulation can mitigate the acute effects of cocaine administration on tonic dopamine levels in the rat nucleus accumbens. Front. Neurosci 17:1061578. https:\/\/doi.org\/10.3389\/fnins.2023.1061578","DOI":"10.3389\/fnins.2023.1061578"},{"key":"5769_CR81","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1046\/j.1471-4159.2001.00326.x","volume":"77","author":"S Rahman","year":"2001","unstructured":"Rahman S, McBride WJ (2001) D1\u2013D2 dopamine receptor interaction within the nucleus accumbens mediates long-loop negative feedback to the ventral tegmental area (VTA). J Neurochem 77:1248\u20131255. https:\/\/doi.org\/10.1046\/j.1471-4159.2001.00326.x","journal-title":"J Neurochem"},{"key":"5769_CR82","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1176\/appi.ajp.158.12.2015","volume":"158","author":"ND Volkow","year":"2001","unstructured":"Volkow ND, Chang L, Wang G-J et al (2001) Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158:2015\u20132021. https:\/\/doi.org\/10.1176\/appi.ajp.158.12.2015","journal-title":"Am J Psychiatry"},{"key":"5769_CR83","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1111\/j.1530-0277.1996.tb05936.x","volume":"20","author":"ND Volkow","year":"1996","unstructured":"Volkow ND, Wang G-J, Fowler JS et al (1996) Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcohol Clin Exp Res 20:1594\u20131598. https:\/\/doi.org\/10.1111\/j.1530-0277.1996.tb05936.x","journal-title":"Alcohol Clin Exp Res"},{"key":"5769_CR84","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S0893-133X(96)00184-4","volume":"16","author":"GJ Wang","year":"1997","unstructured":"Wang GJ, Volkow ND, Fowler JS et al (1997) Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharmacology 16:174\u2013182. https:\/\/doi.org\/10.1016\/S0893-133X(96)00184-4","journal-title":"Neuropsychopharmacology"},{"key":"5769_CR85","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.drugalcdep.2016.01.029","volume":"161","author":"K Okita","year":"2016","unstructured":"Okita K, Ghahremani DG, Payer DE et al (2016) Emotion dysregulation and amygdala dopamine D2-type receptor availability in methamphetamine users. Drug Alcohol Depend 161:163\u2013170. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.01.029","journal-title":"Drug Alcohol Depend"},{"key":"5769_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.795132","author":"BL Giacobbo","year":"2022","unstructured":"Giacobbo BL, \u00d6zalay \u00d6, Mediavilla T et al (2022) The aged striatum: evidence of molecular and structural changes using a longitudinal multimodal approach in mice. Front Aging Neurosci. https:\/\/doi.org\/10.3389\/fnagi.2022.795132","journal-title":"Front Aging Neurosci"},{"key":"5769_CR87","doi-asserted-by":"publisher","first-page":"e1278","DOI":"10.1212\/WNL.0000000000200891","volume":"99","author":"N Karalija","year":"2022","unstructured":"Karalija N, Johansson J, Papenberg G et al (2022) Longitudinal dopamine D2 receptor changes and cerebrovascular health in aging. Neurology 99:e1278\u2013e1289. https:\/\/doi.org\/10.1212\/WNL.0000000000200891","journal-title":"Neurology"},{"key":"5769_CR88","doi-asserted-by":"publisher","unstructured":"Larsen B, Valur O, Finnegan C, et al (2020) Maturation of the human striatal dopamine system revealed by PET and quantitative MRI. Nature Communications, 11(1) https:\/\/doi.org\/10.1038\/s41467-020-14693-3","DOI":"10.1038\/s41467-020-14693-3"},{"key":"5769_CR89","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bbrc.2023.06.005","volume":"671","author":"M Liu","year":"2023","unstructured":"Liu M, Mu S, Han W et al (2023) Dopamine D1 receptor in orbitofrontal cortex to dorsal striatum pathway modulates methamphetamine addiction. Biochem Biophys Res Commun 671:96\u2013104. https:\/\/doi.org\/10.1016\/j.bbrc.2023.06.005","journal-title":"Biochem Biophys Res Commun"},{"key":"5769_CR90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075975","volume":"8","author":"S Hayashizaki","year":"2013","unstructured":"Hayashizaki S, Hirai S, Ito Y et al (2013) Methamphetamine increases locomotion and dopamine transporter activity in dopamine d5 receptor-deficient mice. PLoS One 8:e75975. https:\/\/doi.org\/10.1371\/journal.pone.0075975","journal-title":"PLoS One"},{"key":"5769_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103169","author":"K Vaillancourt","year":"2021","unstructured":"Vaillancourt K, Chen GG, Fiori L et al (2021) Methylation of the tyrosine hydroxylase gene is dysregulated by cocaine dependence in the human striatum. iScience. https:\/\/doi.org\/10.1016\/j.isci.2021.103169","journal-title":"iScience"},{"key":"5769_CR92","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s00213-007-0790-3","volume":"193","author":"D Belin","year":"2007","unstructured":"Belin D, Deroche-Gamonet V, Jaber M (2007) Cocaine-induced sensitization is associated with altered dynamics of transcriptional responses of the dopamine transporter, tyrosine hydroxylase, and dopamine D2 receptors in C57Bl\/6J mice. Psychopharmacology 193:567\u2013578. https:\/\/doi.org\/10.1007\/s00213-007-0790-3","journal-title":"Psychopharmacology"},{"key":"5769_CR93","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0361-9230(87)90201-2","volume":"18","author":"ME Trulson","year":"1987","unstructured":"Trulson ME, Cannon MS, Faegg TS, Raese JD (1987) Tyrosine hydroxylase immunochemistry and quantitative light microscopic studies of the mesolimbic dopamine system in rat brain: effects of chronic methamphetamine administration. Brain Res Bull 18:269\u2013277. https:\/\/doi.org\/10.1016\/0361-9230(87)90201-2","journal-title":"Brain Res Bull"},{"key":"5769_CR94","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/0361-9230(85)90206-0","volume":"15","author":"ME Trulson","year":"1985","unstructured":"Trulson ME, Cannon MS, Faegg TS, Raese JD (1985) Effects of chronic methamphetamine on the nigral-striatal dopamine system in rat brain: tyrosine hydroxylase immunochemistry and quantitative light microscopic studies. Brain Res Bull 15:569\u2013577. https:\/\/doi.org\/10.1016\/0361-9230(85)90206-0","journal-title":"Brain Res Bull"},{"key":"5769_CR95","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00213-006-0316-4","volume":"185","author":"JD Shepard","year":"2006","unstructured":"Shepard JD, Chuang DT, Shaham Y, Morales M (2006) Effect of methamphetamine self-administration on tyrosine hydroxylase and dopamine transporter levels in mesolimbic and nigrostriatal dopamine pathways of the rat. Psychopharmacology 185:505\u2013513. https:\/\/doi.org\/10.1007\/s00213-006-0316-4","journal-title":"Psychopharmacology"},{"key":"5769_CR96","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3109\/00207454.2011.652319","volume":"122","author":"SW Park","year":"2012","unstructured":"Park SW, He Z, Shen X et al (2012) Differential action of methamphetamine on tyrosine hydroxylase and dopamine transport in the nigrostriatal pathway of \u03bc-opioid receptor knockout mice. Int J Neurosci 122:305\u2013313. https:\/\/doi.org\/10.3109\/00207454.2011.652319","journal-title":"Int J Neurosci"},{"key":"5769_CR97","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/jpi.12195","volume":"58","author":"XT Nguyen","year":"2015","unstructured":"Nguyen XT, Lee J, Shin E et al (2015) Liposomal melatonin rescues methamphetamine-elicited mitochondrial burdens, pro-apoptosis, and dopaminergic degeneration through the inhibition PKC\u03b4 gene. J Pineal Res 58:86\u2013106. https:\/\/doi.org\/10.1111\/jpi.12195","journal-title":"J Pineal Res"},{"key":"5769_CR98","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neuro.2015.08.006","volume":"50","author":"SEA McConnell","year":"2015","unstructured":"McConnell SEA, O\u2019Banion MK, Cory-Slechta DA et al (2015) Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation. Neurotoxicology 50:131\u2013141. https:\/\/doi.org\/10.1016\/j.neuro.2015.08.006","journal-title":"Neurotoxicology"},{"key":"5769_CR99","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/1440-1681.12341","volume":"42","author":"D Dang","year":"2015","unstructured":"Dang D, Duong CX, Nam Y et al (2015) Inhibition of protein kinase (PK) C \u03b4 attenuates methamphetamine-induced dopaminergic toxicity via upregulation of phosphorylation of tyrosine hydroxylase at Ser40 by modulation of protein phosphatase 2 A and PKA. Clin Exp Pharmacol Physiol 42:192\u2013201. https:\/\/doi.org\/10.1111\/1440-1681.12341","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"5769_CR100","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.neuint.2011.03.022","volume":"59","author":"E-J Shin","year":"2011","unstructured":"Shin E-J, Duong CX, Nguyen X-K et al (2011) PKC\u03b4 inhibition enhances tyrosine hydroxylase phosphorylation in mice after methamphetamine treatment. Neurochem Int 59:39\u201350. https:\/\/doi.org\/10.1016\/j.neuint.2011.03.022","journal-title":"Neurochem Int"},{"key":"5769_CR101","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.bbr.2018.04.019","volume":"348","author":"KH Struntz","year":"2018","unstructured":"Struntz KH, Siegel JA (2018) Effects of methamphetamine exposure on anxiety-like behavior in the open field test, corticosterone, and hippocampal tyrosine hydroxylase in adolescent and adult mice. Behav Brain Res 348:211\u2013218. https:\/\/doi.org\/10.1016\/j.bbr.2018.04.019","journal-title":"Behav Brain Res"},{"key":"5769_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2023.105491","volume":"164","author":"Y Nago-Iwashita","year":"2023","unstructured":"Nago-Iwashita Y, Moriya Y, Hara S et al (2023) Overexpression of tyrosine hydroxylase in dopaminergic neurons increased sensitivity to methamphetamine. Neurochem Int 164:105491. https:\/\/doi.org\/10.1016\/j.neuint.2023.105491","journal-title":"Neurochem Int"},{"key":"5769_CR103","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1038\/npp.2015.267","volume":"41","author":"I Boileau","year":"2016","unstructured":"Boileau I, Mccluskey T, Tong J et al (2016) Rapid recovery of vesicular dopamine levels in methamphetamine users in early abstinence. Neuropsychopharmacology 41:1179\u20131187. https:\/\/doi.org\/10.1038\/npp.2015.267","journal-title":"Neuropsychopharmacology"},{"key":"5769_CR104","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1124\/jpet.105.085951","volume":"314","author":"JG Truong","year":"2005","unstructured":"Truong JG, Wilkins DG, Baudys J et al (2005) Age-dependent methamphetamine-induced alterations in vesicular monoamine transporter-2 function: implications for neurotoxicity. J Pharmacol Exp Ther 314:1087\u20131092. https:\/\/doi.org\/10.1124\/jpet.105.085951","journal-title":"J Pharmacol Exp Ther"},{"key":"5769_CR105","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/s41593-022-01092-8","volume":"25","author":"L Cutando","year":"2022","unstructured":"Cutando L, Puighermanal E, Castell L et al (2022) Cerebellar dopamine D2 receptors regulate social behaviors. Nat Neurosci 25:900\u2013911. https:\/\/doi.org\/10.1038\/s41593-022-01092-8","journal-title":"Nat Neurosci"},{"key":"5769_CR106","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1016\/j.chemosphere.2015.10.062","volume":"144","author":"R Wang","year":"2016","unstructured":"Wang R, Xu X, Zhu Q (2016) Pubertal exposure to di-(2-ethylhexyl) phthalate influences social behavior and dopamine receptor D2 of adult female mice. Chemosphere 144:1771\u20131779. https:\/\/doi.org\/10.1016\/j.chemosphere.2015.10.062","journal-title":"Chemosphere"},{"key":"5769_CR107","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1523\/JNEUROSCI.0741-21.2021","volume":"42","author":"B Xing","year":"2022","unstructured":"Xing B, Mack NR, Zhang Y-X et al (2022) Distinct roles for prefrontal dopamine D1 and D2 neurons in social hierarchy. J Neurosci 42:313\u2013324. https:\/\/doi.org\/10.1523\/JNEUROSCI.0741-21.2021","journal-title":"J Neurosci"},{"key":"5769_CR108","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1523\/JNEUROSCI.4901-04.2006","volume":"26","author":"BJ Venton","year":"2006","unstructured":"Venton BJ, Seipel AT, Phillips PEM et al (2006) Cocaine increases dopamine release by mobilization of a synapsin-dependent reserve pool. J Neurosci 26:3206\u20133209. https:\/\/doi.org\/10.1523\/JNEUROSCI.4901-04.2006","journal-title":"J Neurosci"},{"key":"5769_CR109","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1124\/jpet.108.146159","volume":"328","author":"SJ Farnsworth","year":"2009","unstructured":"Farnsworth SJ, Volz TJ, Hanson GR, Fleckenstein AE (2009) Cocaine alters vesicular dopamine sequestration and potassium-stimulated dopamine release: the role of D2 receptor activation. J Pharmacol Exp Ther 328:807\u2013812. https:\/\/doi.org\/10.1124\/jpet.108.146159","journal-title":"J Pharmacol Exp Ther"},{"key":"5769_CR110","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.biopsych.2014.06.012","volume":"77","author":"R Narendran","year":"2015","unstructured":"Narendran R, Jedema HP, Lopresti BJ et al (2015) Decreased vesicular monoamine transporter type 2 availability in the striatum following chronic cocaine self-administration in nonhuman primates. Biol Psychiatry 77:488\u2013492. https:\/\/doi.org\/10.1016\/j.biopsych.2014.06.012","journal-title":"Biol Psychiatry"},{"key":"5769_CR111","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1176\/appi.ajp.160.1.47","volume":"160","author":"KY Little","year":"2003","unstructured":"Little KY, Krolewski DM, Zhang L, Cassin BJ (2003) Loss of striatal vesicular monoamine transporter protein (VMAT2) in human cocaine users. Am J Psychiatry 160:47\u201355. https:\/\/doi.org\/10.1176\/appi.ajp.160.1.47","journal-title":"Am J Psychiatry"},{"key":"5769_CR112","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1176\/appi.ajp.2011.11010126","volume":"169","author":"R Narendran","year":"2012","unstructured":"Narendran R, Lopresti BJ, Martinez D et al (2012) In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers. Am J Psychiatry 169:55\u201363. https:\/\/doi.org\/10.1176\/appi.ajp.2011.11010126","journal-title":"Am J Psychiatry"},{"key":"5769_CR113","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/ana.410400312","volume":"40","author":"JM Wilson","year":"1996","unstructured":"Wilson JM, Shannak K, Kish SJ et al (1996) Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Ann Neurol 40:428\u2013439. https:\/\/doi.org\/10.1002\/ana.410400312","journal-title":"Ann Neurol"},{"key":"5769_CR114","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00213-013-3221-7","volume":"231","author":"Q Ren","year":"2014","unstructured":"Ren Q, Zhang J-C, Ma M et al (2014) 7,8-Dihydroxyflavone, a TrkB agonist, attenuates behavioral abnormalities and neurotoxicity in mice after administration of methamphetamine. Psychopharmacology (Berl) 231:159\u2013166. https:\/\/doi.org\/10.1007\/s00213-013-3221-7","journal-title":"Psychopharmacology (Berl)"},{"key":"5769_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37045-3","volume":"14","author":"L Wang","year":"2023","unstructured":"Wang L, Gao M, Wang Q et al (2023) Cocaine induces locomotor sensitization through a dopamine-dependent VTA-mPFC-FrA cortico-cortical pathway in male mice. Nat Commun 14:1568. https:\/\/doi.org\/10.1038\/s41467-023-37045-3","journal-title":"Nat Commun"},{"key":"5769_CR116","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1038\/npp.2011.339","volume":"37","author":"S Koulchitsky","year":"2012","unstructured":"Koulchitsky S, De Backer B, Quertemont E et al (2012) Differential effects of cocaine on dopamine neuron firing in awake and anesthetized rats. Neuropsychopharmacology 37:1559\u20131571. https:\/\/doi.org\/10.1038\/npp.2011.339","journal-title":"Neuropsychopharmacology"},{"key":"5769_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2019.06.012","volume":"98","author":"M Cherner","year":"2019","unstructured":"Cherner M, Watson CW-M, Saloner R et al (2019) Adverse effect of catechol-O-methyltransferase (COMT) Val158Met met\/met genotype in methamphetamine-related executive dysfunction. Addict Behav 98:106023. https:\/\/doi.org\/10.1016\/j.addbeh.2019.06.012","journal-title":"Addict Behav"},{"key":"5769_CR118","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2021.108817","volume":"200","author":"Y Du","year":"2021","unstructured":"Du Y, Lee YB, Graves SM (2021) Chronic methamphetamine-induced neurodegeneration: differential vulnerability of ventral tegmental area and substantia nigra pars compacta dopamine neurons. Neuropharmacology 200:108817. https:\/\/doi.org\/10.1016\/j.neuropharm.2021.108817","journal-title":"Neuropharmacology"},{"key":"5769_CR119","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00213-009-1524-5","volume":"205","author":"M-C Ho","year":"2009","unstructured":"Ho M-C, Cherng CG, Tsai Y-P et al (2009) Chronic treatment with monoamine oxidase-B inhibitors decreases cocaine reward in mice. Psychopharmacology (Berl) 205:141\u2013149. https:\/\/doi.org\/10.1007\/s00213-009-1524-5","journal-title":"Psychopharmacology (Berl)"},{"key":"5769_CR120","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/S0169-328X(01)00013-4","volume":"87","author":"J-P Pepper","year":"2001","unstructured":"Pepper J-P, Baumann MH, Ayestas M, Rothman RB (2001) Inhibition of MAO-A fails to alter cocaine-induced increases in extracellular dopamine and norepinephrine in rat nucleus accumbens. Mol Brain Res 87:184\u2013189. https:\/\/doi.org\/10.1016\/S0169-328X(01)00013-4","journal-title":"Mol Brain Res"},{"key":"5769_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2020.113269","volume":"292","author":"R Saloner","year":"2020","unstructured":"Saloner R, Cherner M, Sundermann EE et al (2020) COMT val158met genotype alters the effects of methamphetamine dependence on dopamine and dopamine-related executive function: preliminary findings. Psychiatry Res 292:113269. https:\/\/doi.org\/10.1016\/j.psychres.2020.113269","journal-title":"Psychiatry Res"},{"key":"5769_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/genes13101768","volume":"13","author":"K Chmielowiec","year":"2022","unstructured":"Chmielowiec K, Chmielowiec J, Masiak J et al (2022) Associations between the COMT rs4680 gene polymorphism and personality dimensions and anxiety in patients with a diagnosis of other stimulants dependence. Genes 13:1768. https:\/\/doi.org\/10.3390\/genes13101768","journal-title":"Genes"},{"key":"5769_CR123","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S0893-133X(98)00092-X","volume":"20","author":"G Bartzokis","year":"1999","unstructured":"Bartzokis G, Beckson M, Newton T et al (1999) Selegiline effects on cocaine-induced changes in medial temporal lobe metabolism and subjective ratings of euphoria. Neuropsychopharmacology 20:582\u2013590. https:\/\/doi.org\/10.1016\/S0893-133X(98)00092-X","journal-title":"Neuropsychopharmacology"},{"key":"5769_CR124","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1038\/npp.2008.126","volume":"33","author":"FW Lohoff","year":"2008","unstructured":"Lohoff FW, Weller AE, Bloch PJ et al (2008) Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence. Neuropsychopharmacology 33:3078\u201384. https:\/\/doi.org\/10.1038\/npp.2008.126","journal-title":"Neuropsychopharmacology"},{"key":"5769_CR125","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1111\/adb.12345","volume":"22","author":"MM Keralapurath","year":"2017","unstructured":"Keralapurath MM, Briggs SB, Wagner JJ (2017) Cocaine self-administration induces changes in synaptic transmission and plasticity in ventral hippocampus. Addict Biol 22:446\u2013456. https:\/\/doi.org\/10.1111\/adb.12345","journal-title":"Addict Biol"},{"key":"5769_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2021.113795","volume":"344","author":"S Jayanthi","year":"2021","unstructured":"Jayanthi S, Daiwile AP, Cadet JL (2021) Neurotoxicity of methamphetamine: main effects and mechanisms. Exp Neurol 344:113795. https:\/\/doi.org\/10.1016\/j.expneurol.2021.113795","journal-title":"Exp Neurol"},{"key":"5769_CR127","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","volume":"20","author":"HJ Forman","year":"2021","unstructured":"Forman HJ, Zhang H (2021) Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat Rev Drug Discov 20:689\u2013709. https:\/\/doi.org\/10.1038\/s41573-021-00233-1","journal-title":"Nat Rev Drug Discov"},{"key":"5769_CR128","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1111\/bph.13544","volume":"174","author":"P Ghezzi","year":"2017","unstructured":"Ghezzi P, Jaquet V, Marcucci F, Schmidt HHHW (2017) The oxidative stress theory of disease: levels of evidence and epistemological aspects. Br J Pharmacol 174:1784\u20131796. https:\/\/doi.org\/10.1111\/bph.13544","journal-title":"Br J Pharmacol"},{"key":"5769_CR129","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1111\/j.1471-4159.2007.05155.x","volume":"105","author":"DM Thomas","year":"2008","unstructured":"Thomas DM, Francescutti-Verbeem DM, Kuhn DM (2008) The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity. J Neurochem 105:605\u2013616. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.05155.x","journal-title":"J Neurochem"},{"key":"5769_CR130","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1111\/adb.12419","volume":"22","author":"EY Jang","year":"2017","unstructured":"Jang EY, Yang CH, Hedges DM et al (2017) The role of reactive oxygen species in methamphetamine self-administration and dopamine release in the nucleus accumbens. Addict Biol 22:1304\u20131315. https:\/\/doi.org\/10.1111\/adb.12419","journal-title":"Addict Biol"},{"key":"5769_CR131","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejphar.2005.09.037","volume":"526","author":"LJMJ Vanderschuren","year":"2005","unstructured":"Vanderschuren LJMJ, Everitt BJ (2005) Behavioral and neural mechanisms of compulsive drug seeking. Eur J Pharmacol 526:77\u201388. https:\/\/doi.org\/10.1016\/j.ejphar.2005.09.037","journal-title":"Eur J Pharmacol"},{"key":"5769_CR132","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.bbi.2024.05.038","volume":"120","author":"SJ Vilca","year":"2024","unstructured":"Vilca SJ, Margetts AV, H\u00f6glund L et al (2024) Microglia contribute to methamphetamine reinforcement and reflect persistent transcriptional and morphological adaptations to the drug. Brain Behav Immun 120:339\u2013351. https:\/\/doi.org\/10.1016\/j.bbi.2024.05.038","journal-title":"Brain Behav Immun"},{"key":"5769_CR133","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1196\/annals.1401.024","volume":"1121","author":"CA Winstanley","year":"2007","unstructured":"Winstanley CA (2007) The orbitofrontal cortex, impulsivity, and addiction. Ann N Y Acad Sci 1121:639\u2013655. https:\/\/doi.org\/10.1196\/annals.1401.024","journal-title":"Ann N Y Acad Sci"},{"key":"5769_CR134","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4103\/0019-5545.33253","volume":"49","author":"S Gupta","year":"2007","unstructured":"Gupta S, Kulhara P (2007) Cellular and molecular mechanisms of drug dependence: an overview and update. Indian J Psychiatry 49:85\u201390. https:\/\/doi.org\/10.4103\/0019-5545.33253","journal-title":"Indian J Psychiatry"},{"key":"5769_CR135","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/hipo.20408","volume":"18","author":"J Swant","year":"2008","unstructured":"Swant J, Stramiello M, Wagner JJ (2008) Postsynaptic dopamine D3 receptor modulation of evoked IPSCs via GABAA receptor endocytosis in rat hippocampus. Hippocampus 18:492\u2013502. https:\/\/doi.org\/10.1002\/hipo.20408","journal-title":"Hippocampus"},{"key":"5769_CR136","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186491","volume":"21","author":"Y Avchalumov","year":"2020","unstructured":"Avchalumov Y, Trenet W, Pi\u00f1a-Crespo J, Mandyam C (2020) SCH23390 reduces methamphetamine self-administration and prevents methamphetamine-induced striatal LTD. Int J Mol Sci 21:6491. https:\/\/doi.org\/10.3390\/ijms21186491","journal-title":"Int J Mol Sci"},{"key":"5769_CR137","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1111\/adb.12388","volume":"22","author":"J-MN Ferland","year":"2017","unstructured":"Ferland J-MN, Winstanley CA (2017) Risk-preferring rats make worse decisions and show increased incubation of craving after cocaine self-administration. Addict Biol 22:991\u20131001. https:\/\/doi.org\/10.1111\/adb.12388","journal-title":"Addict Biol"},{"key":"5769_CR138","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00213-015-4107-7","volume":"233","author":"BD Kangas","year":"2016","unstructured":"Kangas BD, Bergman J (2016) Effects of self-administered methamphetamine on discrimination learning and reversal in nonhuman primates. Psychopharmacology 233:373\u2013380. https:\/\/doi.org\/10.1007\/s00213-015-4107-7","journal-title":"Psychopharmacology"},{"key":"5769_CR139","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neuroscience.2012.01.004","volume":"206","author":"JL Cornish","year":"2012","unstructured":"Cornish JL, Hunt GE, Robins L, McGregor IS (2012) Regional c-Fos and FosB\/\u0394FosB expression associated with chronic methamphetamine self-administration and methamphetamine-seeking behavior in rats. Neuroscience 206:100\u2013114. https:\/\/doi.org\/10.1016\/j.neuroscience.2012.01.004","journal-title":"Neuroscience"},{"key":"5769_CR140","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/syn.20764","volume":"64","author":"M Stramiello","year":"2010","unstructured":"Stramiello M, Wagner JJ (2010) Cocaine enhancement of long-term potentiation in the CA1 region of rat hippocampus: lamina-specific mechanisms of action. Synap N Y N 64:644\u2013648. https:\/\/doi.org\/10.1002\/syn.20764","journal-title":"Synap N Y N"},{"key":"5769_CR141","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.neuron.2012.09.040","volume":"76","author":"JP Britt","year":"2012","unstructured":"Britt JP, Benaliouad F, McDevitt RA et al (2012) Synaptic and behavioral profile of multiple glutamatergic inputs to the nucleus accumbens. Neuron 76:790\u2013803. https:\/\/doi.org\/10.1016\/j.neuron.2012.09.040","journal-title":"Neuron"},{"key":"5769_CR142","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.neuropharm.2015.01.013","volume":"93","author":"LM McFadden","year":"2015","unstructured":"McFadden LM, Vieira-Brock PL, Hanson GR, Fleckenstein AE (2015) Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure. Neuropharmacology 93:146\u2013154. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.01.013","journal-title":"Neuropharmacology"},{"key":"5769_CR143","doi-asserted-by":"publisher","first-page":"7807","DOI":"10.1523\/JNEUROSCI.4652-15.2016","volume":"36","author":"CA Siciliano","year":"2016","unstructured":"Siciliano CA, Fordahl SC, Jones SR (2016) Cocaine self-administration produces long-lasting alterations in dopamine transporter responses to cocaine. J Neurosci 36:7807\u20137816. https:\/\/doi.org\/10.1523\/JNEUROSCI.4652-15.2016","journal-title":"J Neurosci"},{"key":"5769_CR144","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1111\/ejn.12266","volume":"38","author":"MJ Ferris","year":"2013","unstructured":"Ferris MJ, Calipari ES, Melchior JR et al (2013) Paradoxical tolerance to cocaine after initial supersensitivity in drug-use-prone animals. Eur J Neurosci 38:2628\u20132636. https:\/\/doi.org\/10.1111\/ejn.12266","journal-title":"Eur J Neurosci"},{"key":"5769_CR145","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00213-012-2748-3","volume":"224","author":"KM Alvers","year":"2012","unstructured":"Alvers KM, Beckmann JS, Zheng G et al (2012) The effect of VMAT2 inhibitor GZ-793A on the reinstatement of methamphetamine-seeking in rats. Psychopharmacology (Berl) 224:255\u2013262. https:\/\/doi.org\/10.1007\/s00213-012-2748-3","journal-title":"Psychopharmacology (Berl)"},{"key":"5769_CR146","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pbb.2016.01.010","volume":"144","author":"X Gong","year":"2016","unstructured":"Gong X, Yue K, Ma B et al (2016) Levo-tetrahydropalmatine, a natural, mixed dopamine receptor antagonist, inhibits methamphetamine self-administration and methamphetamine-induced reinstatement. Pharmacol Biochem Behav 144:67\u201372. https:\/\/doi.org\/10.1016\/j.pbb.2016.01.010","journal-title":"Pharmacol Biochem Behav"},{"key":"5769_CR147","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.ejphar.2011.02.046","volume":"659","author":"AE Higley","year":"2011","unstructured":"Higley AE, Kiefer SW, Li X et al (2011) Dopamine D3 receptor antagonist SB-277011A inhibits methamphetamine self-administration and methamphetamine-induced reinstatement of drug-seeking in rats. Eur J Pharmacol 659:187\u2013192. https:\/\/doi.org\/10.1016\/j.ejphar.2011.02.046","journal-title":"Eur J Pharmacol"},{"key":"5769_CR148","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.134951","volume":"728","author":"ME Burkovetskaya","year":"2020","unstructured":"Burkovetskaya ME, Small R, Guo L et al (2020) Cocaine self-administration differentially activates microglia in the mouse brain. Neurosci Lett 728:134951. https:\/\/doi.org\/10.1016\/j.neulet.2020.134951","journal-title":"Neurosci Lett"},{"key":"5769_CR149","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/0028-3908(96)84647-8","volume":"35","author":"MP Gygi","year":"1996","unstructured":"Gygi MP, Gygi SP, Johnson M et al (1996) Mechanisms for tolerance to methamphetamine effects. Neuropharmacology 35:751\u2013757. https:\/\/doi.org\/10.1016\/0028-3908(96)84647-8","journal-title":"Neuropharmacology"},{"key":"5769_CR150","first-page":"298","volume":"31","author":"AZ Pietrzykowski","year":"2008","unstructured":"Pietrzykowski AZ, Treistman SN (2008) The molecular basis of tolerance. Alcohol Res Health J Natl Inst Alcohol Abuse Alcohol 31:298\u2013309","journal-title":"Alcohol Res Health J Natl Inst Alcohol Abuse Alcohol"},{"key":"5769_CR151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/clpt.1988.104","volume":"44","author":"JJ Ambre","year":"1988","unstructured":"Ambre JJ, Belknap SM, Nelson J et al (1988) Acute tolerance to cocaine in humans. Clin Pharmacol Ther 44:1\u20138. https:\/\/doi.org\/10.1038\/clpt.1988.104","journal-title":"Clin Pharmacol Ther"},{"key":"5769_CR152","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0022-3565(25)24787-5","volume":"257","author":"RW Foltin","year":"1991","unstructured":"Foltin RW, Fischman MW (1991) Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects. J Pharmacol Exp Ther 257:247\u2013261","journal-title":"J Pharmacol Exp Ther"},{"key":"5769_CR153","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.pbb.2004.02.018","volume":"78","author":"RW Foltin","year":"2004","unstructured":"Foltin RW, Haney M (2004) Intranasal cocaine in humans: acute tolerance, cardiovascular and subjective effects. Pharmacol Biochem Behav 78:93\u2013101. https:\/\/doi.org\/10.1016\/j.pbb.2004.02.018","journal-title":"Pharmacol Biochem Behav"},{"key":"5769_CR154","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ejphar.2006.11.045","volume":"559","author":"JP Danaceau","year":"2007","unstructured":"Danaceau JP, Deering CE, Day JE et al (2007) Persistence of tolerance to methamphetamine-induced monoamine deficits. Eur J Pharmacol 559:46\u201354. https:\/\/doi.org\/10.1016\/j.ejphar.2006.11.045","journal-title":"Eur J Pharmacol"},{"key":"5769_CR155","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ejphar.2003.09.063","volume":"482","author":"KL Johnson-Davis","year":"2003","unstructured":"Johnson-Davis KL, Fleckenstein AE, Wilkins DG (2003) The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity. Eur J Pharmacol 482:151\u2013154. https:\/\/doi.org\/10.1016\/j.ejphar.2003.09.063","journal-title":"Eur J Pharmacol"},{"key":"5769_CR156","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/j.1471-4159.2004.02906.x","volume":"92","author":"DM Thomas","year":"2005","unstructured":"Thomas DM, Kuhn DM (2005) Attenuated microglial activation mediates tolerance to the neurotoxic effects of methamphetamine. J Neurochem 92:790\u2013797. https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02906.x","journal-title":"J Neurochem"},{"key":"5769_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.106839","volume":"207","author":"N Granado","year":"2025","unstructured":"Granado N, Mendieta L, Tizabi Y et al (2025) Attenuated neurotoxicity after repeated methamphetamine binges linked to dopamine transporter (DAT) decline. Neurobiol Dis 207:106839. https:\/\/doi.org\/10.1016\/j.nbd.2025.106839","journal-title":"Neurobiol Dis"},{"key":"5769_CR158","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/s0166-4328(97)83332-3","volume":"84","author":"RP Hammer","year":"1997","unstructured":"Hammer RP, Egilmez Y, Emmett-Oglesby MW (1997) Neural mechanisms of tolerance to the effects of cocaine. Behav Brain Res 84:225\u2013239. https:\/\/doi.org\/10.1016\/s0166-4328(97)83332-3","journal-title":"Behav Brain Res"},{"key":"5769_CR159","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1111\/ejn.14143","volume":"50","author":"RS Hofford","year":"2019","unstructured":"Hofford RS, Russo SJ, Kiraly DD (2019) Neuroimmune mechanisms of psychostimulant and opioid use disorders. Eur J Neurosci 50:2562\u20132573. https:\/\/doi.org\/10.1111\/ejn.14143","journal-title":"Eur J Neurosci"},{"key":"5769_CR160","doi-asserted-by":"publisher","first-page":"e666","DOI":"10.1038\/tp.2015.157","volume":"5","author":"Q Ren","year":"2015","unstructured":"Ren Q, Ma M, Yang C et al (2015) BDNF\u2013TrkB signaling in the nucleus accumbens shell of mice has key role in methamphetamine withdrawal symptoms. Transl Psychiatry 5:e666\u2013e666. https:\/\/doi.org\/10.1038\/tp.2015.157","journal-title":"Transl Psychiatry"},{"key":"5769_CR161","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jad.2017.06.017","volume":"221","author":"W Ren","year":"2017","unstructured":"Ren W, Luan X, Zhang J et al (2017) Brain-derived neurotrophic factor levels and depression during methamphetamine withdrawal. J Affect Disord 221:165\u2013171. https:\/\/doi.org\/10.1016\/j.jad.2017.06.017","journal-title":"J Affect Disord"},{"key":"5769_CR162","unstructured":"CDC (2025) Treatment of substance use disorders. In: Overdose Prev. https:\/\/www.cdc.gov\/overdose-prevention\/treatment\/index.html. Accessed 25 Aug 2025"},{"key":"5769_CR163","unstructured":"McNeely J, Hamilton LK, Whitley SD, et al (2024) Table 3, DSM-5-TR criteria for diagnosing and classifying substance use disorders [a,b]. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK565474\/table\/table-3\/. Accessed 25 Aug 2025"},{"key":"5769_CR164","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1111\/j.1360-0443.2010.03066.x","volume":"105","author":"T Zorick","year":"2010","unstructured":"Zorick T, Nestor L, Miotto K et al (2010) Withdrawal symptoms in abstinent methamphetamine-dependent subjects. Addiction 105:1809\u20131818. https:\/\/doi.org\/10.1111\/j.1360-0443.2010.03066.x","journal-title":"Addiction"},{"issue":"2","key":"5769_CR165","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3109\/00952990.2010.543998","volume":"37","author":"MJ Mancino","year":"2011","unstructured":"Mancino MJ, Gentry BW, Feldman Z et al (2011) Characterizing methamphetamine withdrawal in recently abstinent methamphetamine users: a pilot field study. Am J Drug Alcohol Abuse 37(2):131\u2013136. https:\/\/doi.org\/10.3109\/00952990.2010.543998","journal-title":"Am J Drug Alcohol Abuse"},{"key":"5769_CR166","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107891","volume":"209","author":"RE Fitzpatrick","year":"2020","unstructured":"Fitzpatrick RE, Rubenis AJ, Lubman DI, Verdejo-Garcia A (2020) Cognitive deficits in methamphetamine addiction: independent contributions of dependence and intelligence. Drug Alcohol Depend 209:107891. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.107891","journal-title":"Drug Alcohol Depend"},{"key":"5769_CR167","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1017\/S1355617706060486","volume":"12","author":"A Verdejo-Garc\u00eda","year":"2006","unstructured":"Verdejo-Garc\u00eda A, Bechara A, Recknor EC, P\u00e9rez-Garc\u00eda M (2006) Executive dysfunction in substance dependent individuals during drug use and abstinence: an examination of the behavioral, cognitive and emotional correlates of addiction. J Int Neuropsychol Soc 12:405\u2013415. https:\/\/doi.org\/10.1017\/S1355617706060486","journal-title":"J Int Neuropsychol Soc"},{"key":"5769_CR168","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jsat.2017.08.002","volume":"81","author":"PP Almeida","year":"2017","unstructured":"Almeida PP, de Filho GM A, Malta SM et al (2017) Attention and memory deficits in crack-cocaine users persist over four weeks of abstinence. J Subst Abuse Treat 81:73\u201378. https:\/\/doi.org\/10.1016\/j.jsat.2017.08.002","journal-title":"J Subst Abuse Treat"},{"key":"5769_CR169","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1037\/pha0000245","volume":"27","author":"JJ Mahoney","year":"2019","unstructured":"Mahoney JJ (2019) Cognitive dysfunction in individuals with cocaine use disorder: potential moderating factors and pharmacological treatments. Exp Clin Psychopharmacol 27:203\u2013214. https:\/\/doi.org\/10.1037\/pha0000245","journal-title":"Exp Clin Psychopharmacol"},{"key":"5769_CR170","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1038\/npp.2014.71","volume":"39","author":"M Vonmoos","year":"2014","unstructured":"Vonmoos M, Hulka LM, Preller KH et al (2014) Cognitive impairment in cocaine users is drug-induced but partially reversible: evidence from a longitudinal study. Neuropsychopharmacology 39:2200\u20132210. https:\/\/doi.org\/10.1038\/npp.2014.71","journal-title":"Neuropsychopharmacology"},{"key":"5769_CR171","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1101\/lm.047001.117","volume":"25","author":"AT Brockett","year":"2018","unstructured":"Brockett AT, Pribut HJ, V\u00e1zquez D, Roesch MR (2018) The impact of drugs of abuse on executive function: characterizing long-term changes in neural correlates following chronic drug exposure and withdrawal in rats. Learn Mem Cold Spring Harb 25:461\u2013473. https:\/\/doi.org\/10.1101\/lm.047001.117","journal-title":"Learn Mem Cold Spring Harb"},{"key":"5769_CR172","doi-asserted-by":"publisher","first-page":"11017","DOI":"10.1523\/JNEUROSCI.3321-04.2004","volume":"24","author":"R Hester","year":"2004","unstructured":"Hester R, Garavan H (2004) Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. J Neurosci 24:11017\u201311022. https:\/\/doi.org\/10.1523\/JNEUROSCI.3321-04.2004","journal-title":"J Neurosci"},{"issue":"1","key":"5769_CR173","doi-asserted-by":"publisher","first-page":"222","DOI":"10.26758\/15.1.15","volume":"15","author":"R-A Lunga","year":"2025","unstructured":"Lunga R-A, Dina M-M, Rada C (2025) The role of executive functions and emotional regulation in substance use \u2013 a systematic review. Anthropol Res Stud 15(1):222\u2013246. https:\/\/doi.org\/10.26758\/15.1.15","journal-title":"Anthropol Res Stud"},{"key":"5769_CR174","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.neuint.2018.12.019","volume":"124","author":"H Mizoguchi","year":"2019","unstructured":"Mizoguchi H, Yamada K (2019) Methamphetamine use causes cognitive impairment and altered decision-making. Neurochem Int 124:106\u2013113. https:\/\/doi.org\/10.1016\/j.neuint.2018.12.019","journal-title":"Neurochem Int"},{"key":"5769_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2022.114820","volume":"317","author":"S-M Koopowitz","year":"2022","unstructured":"Koopowitz S-M, Cotton SM, Uhlmann A et al (2022) Executive function in methamphetamine users with and without psychosis. Psychiatry Res 317:114820. https:\/\/doi.org\/10.1016\/j.psychres.2022.114820","journal-title":"Psychiatry Res"},{"key":"5769_CR176","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1080\/13803390802484797","volume":"31","author":"EAA van der Plas","year":"2009","unstructured":"van der Plas EAA, Crone EA, van den Wildenberg WPM et al (2009) Executive control deficits in substance-dependent individuals: a comparison of alcohol, cocaine, and methamphetamine and of men and women. J Clin Exp Neuropsychol 31:706\u2013719. https:\/\/doi.org\/10.1080\/13803390802484797","journal-title":"J Clin Exp Neuropsychol"},{"key":"5769_CR177","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1521-0391.2009.00014.x","volume":"19","author":"MH Leamon","year":"2010","unstructured":"Leamon MH, Flower K, Salo RE et al (2010) Methamphetamine and paranoia: the methamphetamine experience questionnaire. Am J Addict 19:155\u2013168. https:\/\/doi.org\/10.1111\/j.1521-0391.2009.00014.x","journal-title":"Am J Addict"},{"key":"5769_CR178","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.drugalcdep.2016.01.018","volume":"161","author":"R McKetin","year":"2016","unstructured":"McKetin R, Dawe S, Burns RA et al (2016) The profile of psychiatric symptoms exacerbated by methamphetamine use. Drug Alcohol Depend 161:104\u2013109. https:\/\/doi.org\/10.1016\/j.drugalcdep.2016.01.018","journal-title":"Drug Alcohol Depend"},{"key":"5769_CR179","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cpr.2014.08.002","volume":"34","author":"MHJ Schulte","year":"2014","unstructured":"Schulte MHJ, Cousijn J, den Uyl TE et al (2014) Recovery of neurocognitive functions following sustained abstinence after substance dependence and implications for treatment. Clin Psychol Rev 34:531\u2013550. https:\/\/doi.org\/10.1016\/j.cpr.2014.08.002","journal-title":"Clin Psychol Rev"},{"key":"5769_CR180","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068791","volume":"8","author":"G Wang","year":"2013","unstructured":"Wang G, Shi J, Chen N et al (2013) Effects of length of abstinence on decision-making and craving in methamphetamine abusers. PLoS One 8:e68791. https:\/\/doi.org\/10.1371\/journal.pone.0068791","journal-title":"PLoS One"},{"key":"5769_CR181","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/add.16001","volume":"118","author":"J Stellern","year":"2023","unstructured":"Stellern J, Xiao KB, Grennell E et al (2023) Emotion regulation in substance use disorders: a systematic review and meta-analysis. Addiction 118:30\u201347. https:\/\/doi.org\/10.1111\/add.16001","journal-title":"Addiction"},{"key":"5769_CR182","doi-asserted-by":"publisher","first-page":"759","DOI":"10.3390\/psychiatryint5040052","volume":"5","author":"V Ricci","year":"2024","unstructured":"Ricci V, Martinotti G, Maina G (2024) Substance-induced psychosis: diagnostic challenges and phenomenological insights. Psychiatry Int 5:759\u2013772. https:\/\/doi.org\/10.3390\/psychiatryint5040052","journal-title":"Psychiatry Int"},{"key":"5769_CR183","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.drugalcdep.2018.07.029","volume":"192","author":"AW Carrico","year":"2018","unstructured":"Carrico AW, G\u03ccmez W, Jain J et al (2018) Randomized controlled trial of a positive affect intervention for methamphetamine users. Drug Alcohol Depend 192:8\u201315. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.07.029","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"5769_CR184","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-021-05615-9","volume":"22","author":"S Menglu","year":"2021","unstructured":"Menglu S, Suyong Y, Xiaoyan W et al (2021) Cognitive effectiveness of high-intensity interval training for individuals with methamphetamine dependence: a study protocol for randomised controlled trial. Trials 22(1):650. https:\/\/doi.org\/10.1186\/s13063-021-05615-9","journal-title":"Trials"},{"key":"5769_CR185","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/S0149-7634(99)00031-7","volume":"23","author":"DC Blanchard","year":"1999","unstructured":"Blanchard DC, Blanchard RJ (1999) Cocaine potentiates defensive behaviors related to fear and anxiety. Neurosci Biobehav Rev 23:981\u2013991. https:\/\/doi.org\/10.1016\/S0149-7634(99)00031-7","journal-title":"Neurosci Biobehav Rev"},{"key":"5769_CR186","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1111\/j.1360-0443.2009.02564.x","volume":"104","author":"CC Cruickshank","year":"2009","unstructured":"Cruickshank CC, Dyer KR (2009) A review of the clinical pharmacology of methamphetamine. Addiction 104:1085\u20131099. https:\/\/doi.org\/10.1111\/j.1360-0443.2009.02564.x","journal-title":"Addiction"},{"key":"5769_CR187","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1521-0391.2010.00061.x","volume":"19","author":"S Glasner-Edwards","year":"2010","unstructured":"Glasner-Edwards S, Mooney LJ, Marinelli-Casey P et al (2010) Anxiety disorders among methamphetamine dependent adults: association with post-treatment functioning. Am J Addict 19:385\u2013390. https:\/\/doi.org\/10.1111\/j.1521-0391.2010.00061.x","journal-title":"Am J Addict"},{"issue":"1","key":"5769_CR188","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1177\/0885066613507420","volume":"30","author":"T Plush","year":"2015","unstructured":"Plush T, Shakespeare W, Jacobs D et al (2015) Cocaine-induced agitated delirium: a case report and review. J Intensive Care Med 30(1):49\u201357. https:\/\/doi.org\/10.1177\/0885066613507420","journal-title":"J Intensive Care Med"},{"key":"5769_CR189","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-024-01015-9","volume":"21","author":"R Shiraly","year":"2024","unstructured":"Shiraly R, Jazayeri SA, Seifaei A et al (2024) Suicidal thoughts and behaviors among untreated illicit substance users: a population-based study. Harm Reduct J 21:1\u20139. https:\/\/doi.org\/10.1186\/s12954-024-01015-9","journal-title":"Harm Reduct J"},{"key":"5769_CR190","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.neuropharm.2014.04.002","volume":"87","author":"KA Phillips","year":"2014","unstructured":"Phillips KA, Epstein DH, Preston KL (2014) Psychostimulant addiction treatment. Neuropharmacology 87:150\u2013160. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.04.002","journal-title":"Neuropharmacology"},{"key":"5769_CR191","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aax1532","volume":"5","author":"KM Kampman","year":"2019","unstructured":"Kampman KM (2019) The treatment of cocaine use disorder. Sci Adv 5:eaax1532. https:\/\/doi.org\/10.1126\/sciadv.aax1532","journal-title":"Sci Adv"},{"key":"5769_CR192","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1176\/appi.ajp.162.8.1452","volume":"162","author":"KM Carroll","year":"2005","unstructured":"Carroll KM, Onken LS (2005) Behavioral therapies for drug abuse. Am J Psychiatry 162:1452\u20131460. https:\/\/doi.org\/10.1176\/appi.ajp.162.8.1452","journal-title":"Am J Psychiatry"},{"key":"5769_CR193","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1037\/0022-006X.66.5.832","volume":"66","author":"PM Maude-Griffin","year":"1998","unstructured":"Maude-Griffin PM, Hohenstein JM, Humfleet GL et al (1998) Superior efficacy of cognitive-behavioral therapy for urban crack cocaine abusers: main and matching effects. J Consult Clin Psychol 66:832\u2013837. https:\/\/doi.org\/10.1037\/0022-006X.66.5.832","journal-title":"J Consult Clin Psychol"},{"issue":"1","key":"5769_CR194","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007024.pub3","volume":"2024","author":"F Traccis","year":"2024","unstructured":"Traccis F, Minozzi S, Trogu E et al (2024) Disulfiram for the treatment of cocaine dependence. Cochrane Database Syst Rev (1):CD007024. https:\/\/doi.org\/10.1002\/14651858.CD007024.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"5769_CR195","doi-asserted-by":"publisher","first-page":"398","DOI":"10.4088\/JCP.14m09377","volume":"77","author":"L Balda\u00e7ara","year":"2016","unstructured":"Balda\u00e7ara L, Cogo-Moreira H, Parreira BL et al (2016) Efficacy of topiramate in the treatment of crack cocaine dependence: a double-blind, randomized, placebo-controlled trial. J Clin Psychiatry 77:398\u2013406. https:\/\/doi.org\/10.4088\/JCP.14m09377","journal-title":"J Clin Psychiatry"},{"key":"5769_CR196","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1001\/jamapsychiatry.2013.2295","volume":"70","author":"BA Johnson","year":"2013","unstructured":"Johnson BA, Ait-Daoud N, Wang X-Q et al (2013) Topiramate for the treatment of cocaine addiction: a randomized clinical trial. JAMA Psychiatr 70:1338\u20131346. https:\/\/doi.org\/10.1001\/jamapsychiatry.2013.2295","journal-title":"JAMA Psychiatr"},{"key":"5769_CR197","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.drugalcdep.2004.03.008","volume":"75","author":"KM Kampman","year":"2004","unstructured":"Kampman KM, Pettinati H, Lynch KG et al (2004) A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend 75:233\u2013240. https:\/\/doi.org\/10.1016\/j.drugalcdep.2004.03.008","journal-title":"Drug Alcohol Depend"},{"key":"5769_CR198","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.drugalcdep.2013.05.026","volume":"133","author":"KM Kampman","year":"2013","unstructured":"Kampman KM, Pettinati HM, Lynch KG et al (2013) A double-blind, placebo-controlled trial of topiramate for the treatment of comorbid cocaine and alcohol dependence. Drug Alcohol Depend 133:94\u201399. https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.05.026","journal-title":"Drug Alcohol Depend"},{"key":"5769_CR199","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.drugalcdep.2014.02.024","volume":"138","author":"M Nuijten","year":"2014","unstructured":"Nuijten M, Blanken P, van den Brink W, Hendriks V (2014) Treatment of crack-cocaine dependence with topiramate: a randomized controlled feasibility trial in The Netherlands. Drug Alcohol Depend 138:177\u2013184. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.02.024","journal-title":"Drug Alcohol Depend"},{"key":"5769_CR200","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.drugalcdep.2014.03.033","volume":"140","author":"A Umbricht","year":"2014","unstructured":"Umbricht A, DeFulio A, Winstanley EL et al (2014) Topiramate for cocaine dependence during methadone maintenance treatment: a randomized controlled trial. Drug Alcohol Depend 140:92\u2013100. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.03.033","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"5769_CR201","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1111\/add.13328","volume":"111","author":"M Singh","year":"2016","unstructured":"Singh M, Keer D, Klimas J et al (2016) Topiramate for cocaine dependence: a systematic review and meta-analysis of randomized controlled trials. Addiction 111(8):1337\u20131346. https:\/\/doi.org\/10.1111\/add.13328","journal-title":"Addiction"},{"key":"5769_CR202","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2014.02.512","volume":"140","author":"O Rass","year":"2014","unstructured":"Rass O, Umbricht A, Bigelow GE et al (2014) Topiramate impairs cognitive function in cocaine-dependent individuals maintained on methadone. Drug Alcohol Depend 140:e183. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.02.512","journal-title":"Drug Alcohol Depend"},{"key":"5769_CR203","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1001\/archpsyc.61.3.264","volume":"61","author":"KM Carroll","year":"2004","unstructured":"Carroll KM, Fenton LR, Ball SA et al (2004) Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. Arch Gen Psychiatry 61:264\u2013272. https:\/\/doi.org\/10.1001\/archpsyc.61.3.264","journal-title":"Arch Gen Psychiatry"},{"key":"5769_CR204","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1124\/mi.9.4.6","volume":"9","author":"M Gaval-Cruz","year":"2009","unstructured":"Gaval-Cruz M, Weinshenker D (2009) Mechanisms of disulfiram-induced cocaine abstinence: antabuse and cocaine relapse. Mol Interv 9:175\u2013187. https:\/\/doi.org\/10.1124\/mi.9.4.6","journal-title":"Mol Interv"},{"key":"5769_CR205","doi-asserted-by":"publisher","unstructured":"Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram - Carroll - 1998 - Addiction - Wiley Online Library. https:\/\/onlinelibrary-wiley-com.leo.lib.unomaha.edu\/doi\/,\u00a0https:\/\/doi.org\/10.1046\/j.1360-0443.1998.9357137.x. Accessed 17 Dec 2025","DOI":"10.1046\/j.1360-0443.1998.9357137.x"},{"key":"5769_CR206","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.drugalcdep.2015.12.036","volume":"160","author":"KM Carroll","year":"2016","unstructured":"Carroll KM, Nich C, Petry NM et al (2016) A randomized factorial trial of disulfiram and contingency management to enhance cognitive behavioral therapy for cocaine dependence. Drug Alcohol Depend 160:135\u2013142. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.12.036","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"5769_CR207","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0376-8716(02)00335-6","volume":"70","author":"CA Dackis","year":"2003","unstructured":"Dackis CA, Lynch KG, Yu E et al (2003) Modafinil and cocaine: a double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend 70(1):29\u201337. https:\/\/doi.org\/10.1016\/S0376-8716(02)00335-6","journal-title":"Drug Alcohol Depend"},{"key":"5769_CR208","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/sj.npp.1301472","volume":"33","author":"CL Hart","year":"2008","unstructured":"Hart CL, Haney M, Vosburg SK et al (2008) Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology 33:761\u2013768. https:\/\/doi.org\/10.1038\/sj.npp.1301472","journal-title":"Neuropsychopharmacology"},{"key":"5769_CR209","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/00952990600920425","volume":"32","author":"R Malcolm","year":"2006","unstructured":"Malcolm R, Swayngim K, Donovan JL et al (2006) Modafinil and cocaine interactions. Am J Drug Alcohol Abuse 32:577\u2013587. https:\/\/doi.org\/10.1080\/00952990600920425","journal-title":"Am J Drug Alcohol Abuse"},{"key":"5769_CR210","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.drugalcdep.2014.05.008","volume":"141","author":"CD Verrico","year":"2014","unstructured":"Verrico CD, Haile CN, Mahoney JJ III et al (2014) Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study. Drug Alcohol Depend 141:72\u201378. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.05.008","journal-title":"Drug Alcohol Depend"},{"key":"5769_CR211","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1001\/jama.2009.351","volume":"301","author":"ND Volkow","year":"2009","unstructured":"Volkow ND, Fowler JS, Logan J et al (2009) Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA 301:1148\u20131154. https:\/\/doi.org\/10.1001\/jama.2009.351","journal-title":"JAMA"},{"key":"5769_CR212","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jsat.2011.12.014","volume":"43","author":"CA Dackis","year":"2012","unstructured":"Dackis CA, Kampman KM, Lynch KG et al (2012) A double-blind, placebo-controlled trial of modafinil for cocaine dependence. J Subst Abuse Treat 43:303\u2013312. https:\/\/doi.org\/10.1016\/j.jsat.2011.12.014","journal-title":"J Subst Abuse Treat"},{"key":"5769_CR213","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.drugalcdep.2009.04.015","volume":"104","author":"AL Anderson","year":"2009","unstructured":"Anderson AL, Reid MS, Li S-H et al (2009) Modafinil for the treatment of cocaine dependence. Drug Alcohol Depend 104:133. https:\/\/doi.org\/10.1016\/j.drugalcdep.2009.04.015","journal-title":"Drug Alcohol Depend"},{"key":"5769_CR214","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/sj.npp.1301481","volume":"33","author":"AM Elkashef","year":"2008","unstructured":"Elkashef AM, Rawson RA, Anderson AL et al (2008) Bupropion for the treatment of methamphetamine dependence. Neuropsychopharmacology 33:1162\u20131170. https:\/\/doi.org\/10.1038\/sj.npp.1301481","journal-title":"Neuropsychopharmacology"},{"key":"5769_CR215","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1038\/sj.npp.1300979","volume":"31","author":"TF Newton","year":"2006","unstructured":"Newton TF, Roache JD, De La Garza R et al (2006) Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology 31:1537\u20131544. https:\/\/doi.org\/10.1038\/sj.npp.1300979","journal-title":"Neuropsychopharmacology"},{"key":"5769_CR216","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1056\/NEJMoa2020214","volume":"384","author":"MH Trivedi","year":"2021","unstructured":"Trivedi MH, Walker R, Ling W et al (2021) Bupropion and naltrexone in methamphetamine use disorder. N Engl J Med 384:140\u2013153. https:\/\/doi.org\/10.1056\/NEJMoa2020214","journal-title":"N Engl J Med"},{"key":"5769_CR217","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1111\/add.16529","volume":"119","author":"MJ Li","year":"2024","unstructured":"Li MJ, Chau B, Belin T et al (2024) Extended observation of reduced methamphetamine use with combined naltrexone plus bupropion in the ADAPT-2 trial. Addiction 119:1840\u20131845. https:\/\/doi.org\/10.1111\/add.16529","journal-title":"Addiction"},{"key":"5769_CR218","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1038\/npp.2015.83","volume":"40","author":"LA Ray","year":"2015","unstructured":"Ray LA, Bujarski S, Courtney KE et al (2015) The effects of naltrexone on subjective response to methamphetamine in a clinical sample: a double-blind, placebo-controlled laboratory study. Neuropsychopharmacology 40:2347\u20132356. https:\/\/doi.org\/10.1038\/npp.2015.83","journal-title":"Neuropsychopharmacology"},{"key":"5769_CR219","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2020.112971","volume":"399","author":"Z Wang","year":"2021","unstructured":"Wang Z, Guo L, Han X et al (2021) Naltrexone attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in mice. Behav Brain Res 399:112971. https:\/\/doi.org\/10.1016\/j.bbr.2020.112971","journal-title":"Behav Brain Res"},{"key":"5769_CR220","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1007\/s00213-019-5176-9","volume":"236","author":"F Yang","year":"2019","unstructured":"Yang F, Kosten TR (2019) Psychopharmacology: neuroimmune signaling in psychiatric disease-developing vaccines against abused drugs using toll-like receptor agonists. Psychopharmacology (Berl) 236:2899\u20132907. https:\/\/doi.org\/10.1007\/s00213-019-5176-9","journal-title":"Psychopharmacology (Berl)"},{"key":"5769_CR221","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2023.1259041","author":"JM Loftis","year":"2023","unstructured":"Loftis JM, Ramani S, Firsick EJ et al (2023) Immunotherapeutic treatment of inflammation in mice exposed to methamphetamine. Front Psychiatry. https:\/\/doi.org\/10.3389\/fpsyt.2023.1259041","journal-title":"Front Psychiatry"},{"key":"5769_CR222","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2024.100744","volume":"36","author":"EN Grodin","year":"2024","unstructured":"Grodin EN (2024) Neuroimmune modulators as novel pharmacotherapies for substance use disorders. Brain Behav Immun-Health 36:100744. https:\/\/doi.org\/10.1016\/j.bbih.2024.100744","journal-title":"Brain Behav Immun-Health"},{"key":"5769_CR223","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.pbb.2014.10.001","volume":"127","author":"N Soni","year":"2014","unstructured":"Soni N, Reddy BVK, Kumar P (2014) GLT-1 transporter: an effective pharmacological target for various neurological disorders. Pharmacol Biochem Behav 127:70\u201381. https:\/\/doi.org\/10.1016\/j.pbb.2014.10.001","journal-title":"Pharmacol Biochem Behav"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05769-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-05769-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-05769-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T08:27:06Z","timestamp":1772699226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-05769-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":223,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5769"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-05769-0","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"28 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"487"}}